These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Interferon-producing and cytotoxic activity of natural killer cells in multiple sclerosis patients]. Sorokin AM; Koval'chuk LV; Tunkel' OI; Cheknev SB Zh Nevropatol Psikhiatr Im S S Korsakova; 1987; 87(2):211-5. PubMed ID: 2437743 [TBL] [Abstract][Full Text] [Related]
4. [Indicators of cellular immunity in patients with multiple sclerosis]. Dziuba AN; Frolov VM; Gaĭdash IS Zh Nevropatol Psikhiatr Im S S Korsakova; 1992; 92(2):12-4. PubMed ID: 1326155 [TBL] [Abstract][Full Text] [Related]
5. [Role of immunoregulatory cells and natural killers in the pathogenesis of multiple sclerosis]. Tunkel' OI; Saidov MZ; Cheredeev AN; Koval'chuk LV; Skriabina EG Zh Nevropatol Psikhiatr Im S S Korsakova; 1983; 83(6):880-5. PubMed ID: 6224384 [TBL] [Abstract][Full Text] [Related]
6. Multiple sclerosis as a disease of immune regulation. Waksman BH; Reynolds WE Proc Soc Exp Biol Med; 1984 Mar; 175(3):282-94. PubMed ID: 6229799 [No Abstract] [Full Text] [Related]
7. Viral antibodies in multiple sclerosis. Norrby E Prog Med Virol; 1978; 24():1-39. PubMed ID: 704893 [No Abstract] [Full Text] [Related]
8. [The lymphocyte abnormality in CNS disease]. Matsubara H; Igata A No To Shinkei; 1983 May; 35(5):423-31. PubMed ID: 6354216 [No Abstract] [Full Text] [Related]
10. Cellular immunology in multiple sclerosis. A review through 1984. Baumhefner RW; Tourtellotte WW Concepts Immunopathol; 1985; 2():151-88. PubMed ID: 2439204 [No Abstract] [Full Text] [Related]
11. Lymphocyte phenotypes in the multiple sclerosis lesion--what do they mean? Zweiman B; Lisak RP Ann Neurol; 1986 Jun; 19(6):588-9. PubMed ID: 2942098 [No Abstract] [Full Text] [Related]
12. Cell-mediated cytotoxicity in vitro: target-cell recognition and effector-cell requirements. Perlmann P; Holm G; Stejskal V Transplant Proc; 1973 Dec; 5(4):1625-9. PubMed ID: 4272822 [No Abstract] [Full Text] [Related]
13. Serum antimyelin factors in experimental allergic encephalomyelitis and multiple sclerosis. Seil FJ; Agrawal HC Prog Clin Biol Res; 1984; 146():199-206. PubMed ID: 6201891 [No Abstract] [Full Text] [Related]
14. Mixed lymphocyte culture determinants, measles infection and multiple sclerosis. Platz P; Dupont B; Fog T; Ryder L; Thomsen M; Svejgaard A; Jersild C Proc R Soc Med; 1974 Nov; 67(11):1133-6. PubMed ID: 4140520 [No Abstract] [Full Text] [Related]
15. Transformation capacity of human blood lymphocytes in relation to their specific gravity; another heterogeneity of lymphocyte reactivity. Schut BJ; Loos HA; Roos MT; Pinkster T; Zeijlemaker WP; Schellekens PT Eur J Immunol; 1978 Jun; 8(6):386-93. PubMed ID: 149669 [No Abstract] [Full Text] [Related]
16. Stimulation induced by autologous lymphocyte subpopulations from healthy subjects in mixed lymphocyte reaction (MLR). Semenzato G; Amadori G; Piazza I; Pezzutto A; Colombatti M; Gasparotto G Transplant Proc; 1979 Jun; 11(2):1373-4. PubMed ID: 157574 [No Abstract] [Full Text] [Related]
17. Cell-mediated hypersensitivity and disease activity in multiple sclerosis. Sheremata W; Cosgrove JB; Robb P Trans Am Neurol Assoc; 1973; 98():306-9. PubMed ID: 4784962 [No Abstract] [Full Text] [Related]
18. [Regulation of immune system functions]. Petrov RV Arkh Patol; 1983; 45(4):3-11. PubMed ID: 6191742 [No Abstract] [Full Text] [Related]
19. New concepts in the immunopathogenesis of multiple sclerosis. Hemmer B; Archelos JJ; Hartung HP Nat Rev Neurosci; 2002 Apr; 3(4):291-301. PubMed ID: 11967559 [No Abstract] [Full Text] [Related]
20. Current studies on lymphocyte immunological functions. Astaldi G; Lisiewicz J; Yalçin B; Cichocki T Boll Ist Sieroter Milan; 1972; 51(5):379-92. PubMed ID: 4120925 [No Abstract] [Full Text] [Related] [Next] [New Search]